Last reviewed · How we verify

NCT04275128

Cooled Versus Conventional Genicular Radiofrequency Ablation for Chronic Knee Pain

Terminated Last updated 28 September 2020
What this trial tests

trial testing Cooled radiofrequency ablation in Chronic Knee Pain in 1 participant. Terminated before completion.

Timeline
11 July 2020
Primary endpoint
24 September 2020
24 September 2020

Quick facts

Lead sponsorHenry Ford Health System
StatusTerminated
Study typeOBSERVATIONAL
Enrollment1
Start date11 July 2020
Primary completion24 September 2020
Estimated completion24 September 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Henry Ford Health System — full company profile →

Who can join

18 and older, any sex, with Chronic Knee Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective observational study seeks to compare pain relief and disability following cooled radiofrequency ablation (Coolief) versus conventional genicular nerve ablation in patients with chronic knee pain. Patients' NRS for pain, WOMAC, and ODI score at baseline and 1, 3 and 6 months after treatment will be used to evaluate whether Coolief is more effective at reducing disability and improving pain relief.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Knee Pain

Currently open trials in the same condition.

Other Henry Ford Health System trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04275128.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing